Health Education England (HEE) has announced launch of a new funded Independent Prescriber courses for pharmacists to be made available before March 2022.
Places are available for both Independent Prescribing (IP) and Clinically Enhanced Independent Prescribing (CEPIP), and eligible pharmacists are encouraged to apply to the course providers directly.
These courses will be allocated on a first come, first served basis, and a further round of funded Independent Prescriber training will be made available from Autumn 2022.
The independent prescriber guide offers practical guidance and support on the prescriber role, such as how to become an independent prescriber, applying for an IP course, or expanding the scope of practice.
Boots is planning to invest more than £3.5 million to accelerate its capacity to offer prescribing services in its stores across England.
The company is inviting 500 of its pharmacists to apply for a bursary which will cover the cost of pharmacist independent prescriber (PIP) courses starting this
September.
The value of the bursary is up to £7,000 per pharmacist, and it will enable time off work for those who need it to complete the training.
The move by Boots will support its current pharmacists to gain this qualification via courses accredited by the General Pharmaceutical Council (GPhC). From 2026,
all qualified pharmacists will be able to prescribe as part of new curricula for pharmacy degrees.
Under current GPhC guidelines and with an independent prescribing qualification, pharmacists can prescribe autonomously for any condition within their clinical
competence.
Marc Donovan, the chief pharmacist at Boots, said the ambition of the company was "to have a pharmacist prescriber available at every store".
Health Education England (HEE) has developed funded training offers for community pharmacists, including locums aiming to become independent prescribers.
Almost 3000 independent prescribing training places will be available to pharmacists from March 2023.
This training enables pharmacists to support patients from diagnosis to prescribing, and to provide advice and follow-up - while also helping them to feel confident
and prepared for the new challenges of their role.
Courses will be available between April 2023 and March 2024, with several universities offering multiple dates for cohort intakes. Start dates will depend on the
university provider.
Training will enable the provision of new models of care: supporting patients from diagnosis to prescribing, providing advice and follow-up, and preparing pharmacists
to provide clinical care, as pharmacy services become more widespread within emerging clinical pathways.
The Pharmacists' Defence Association (PDA) says the pharmacy regulator should maintain a two-year post qualification eligibility criteria, in addition to
the qualitative measures being introduced which would be in the best interest of patient safety, before a pharmacist is allowed to commence an IP course.
The association was responding to an announcement by the GPhC's move to scrap the two year requirement for Independent Prescribing (IP) course.
"The PDA accepts that the qualitative approach could mean greater individual consideration of potential IP course candidates and the two-year measure could have
sometimes been a blunt tool. However, the PDA is already seeing cases of patient harm and allegations around fitness to practice arising from IP," the association
said.
The association also said that it supports individual pharmacists with near misses, as well as actual incidents, giving the organisation possibly the most
comprehensive understanding of risk.
Frontline pharmacists also recognise these issues and in a survey of over 1,000 pharmacists undertaken by the PDA in late 2021, of those who had 2+ years'
experience of practice and who were already independent prescribers, 90 per cent said the qualifying period should be two years or more.
The Pharmacists' Defence Association (PDA) has raised concern over the Health Education England (HEE)'s decision on cutting funding to independent prescribing
training.
The HEE has reportedly decided that no funding will be available to back-fill trainees undertaking the pharmacist independent prescribing (PIP) qualification, or
for the supervision of trainees by DPPs and DMPs.
The PDA noted that, whilst all successful trainee pharmacists will be entering the GPhC register as independent prescribers from 2026, the existing pharmacist
workforce is reliant on opportunities to undertake prescriber training through release from their employment, and the ability to secure a Designated Medical
Practitioner (DMP) or Designated Prescribing Practitioner (DPP) to support the 90 days of supervised practice required.
The association said it has already heard examples of potential DMPs or DPPs requesting a significant fee from trainees before they will provide supervision,
adding that meeting that request is not an option for many.
"This latest decision threatens to undermine the availability of the large numbers of pharmacists seeing supervisors as more IP training becomes available," it
said in a statement.
Centre for Pharmacy PostGraduate Education (CPPE) has announced the launch of a new learning programme, Preparing to train as an independent prescriber.
The programme aims to build the confidence and competence of pharmacists who are planning to apply and train as independent prescribers and is open to pharmacists
from all sectors of practice, including community pharmacists who are planning to commence their independent prescriber training with a Higher Education Institute
(HEI).
The course is made up of four main components, including a self-directed e-course and self-assessment framework, a mandatory online workshop to support you to review
your self-assessment of competencies, an optional online workshop to support your readiness for academic writing and reflective practice, and optional peer support
sessions, providing the opportunity for you to develop your professional network and establish communities of practice.
The General Pharmaceutical Council (GPhC) has announced that the new requirement for independent prescribing courses will be applicable from 1st of October 2022.
Pharmacists currently taking independent prescribing courses and those who apply before 1 October won't be affected by the changes.
The new guidance was agreed at the council meeting on 8 September and went to the initial education and training Advisory Group on 22 September where it was well
received, the GPhC said.
"The guidance is now being finalised to reflect the discussions at the Council meeting and the initial education and training advisory group and will be published
in October."
The new guidance is relevant for both course providers and applicants and gives some specific suggestions and examples of what we may expect. It will support
consistency in the way education providers applied the new standards and will help individual pharmacists to understand the relevant experience they would need
before enrolling on a course.
Pharmacists with 'relevant experience in a pharmacy setting' can enroll for accredited independent prescribing course, as the General Pharmaceutical Council (GPhC) has decided to scrap the requirement of spending at least two years on the register and having previous experience in a specified clinical or therapeutic area before enrolling for the course.
The GPhC Council meeting held on Thursday instead proposed that applicants must have "relevant experience in a pharmacy setting and be able to recognise, understand
and articulate the skills and attributes required by a prescriber." This experience and awareness will act as the basis of their prescribing practice whilst training.
The regulator noted that the majority of stakeholder organisations, including the Chief Pharmaceutical Officers, the Royal Pharmaceutical Society and the statutory education bodies, were in favour of removing the requirement in a consultation on the topic.
They highlighted that a specific two-year period was not in itself a robust indication of whether an individual was ready to become a prescriber.
They also highlighted that the rapidly developing roles in the profession meant more pharmacists were likely to gain the necessary experience more quickly than in the past. A smaller number of organisations and a larger minority of individuals were opposed, citing that a specific two-year period gave pharmacists the time they needed to develop experience and confidence before being ready to enrol on a course.
A new NHS-funded training course on clinical examination skills has been announced by Health Education England (HEE) for 10,000 community pharmacists.
The training will be provided by CliniSkills and be coordinated by HEE with the Pharmacy Integration Programme at NHS England.
With pre-registration now open to all community pharmacists, the programme will be available from 17th April 2023 and will until March 2024.
It will be delivered online, with optional face-to-face attendance for pharmacists who would find this beneficial.
Pharmacists will be required to complete a module on history taking and identification of serious conditions and can then choose from four optional modules,
which cover the following themes: dermatology; cardiology; paediatrics; and ear, nose and throat.
The training is designed to be complementary to the independent prescribing training and can be completed prior to or after an independent prescribing training
course. It is open to all community pharmacists including those that work part time and locums.
The Council of the Pharmaceutical Society NI (PSNI) to remove the two-year requirement as a registered pharmacist to have an Independent Prescriber (IP)
annotation on the pharmacy register in Northern Ireland.
It has further endorsed that the two-year requirement for entry onto stand-alone pharmacist independent prescribing courses be removed and replaced with an
assessment before admission, by course providers, based upon guidance provided by the regulator.
In conjunction with the Department of Health, the PSNI will now work towards a further public consultation on the necessary legislative changes.
Dr Jim Livingstone, president of the PSNI, said: "The Department of Health has set a clear direction which will see pharmacist independent prescribers becoming
increasingly important in the delivery of pharmacy services in Northern Ireland. Our role is to protect the public, but we are clear that our regulatory objective
should not be an unnecessary barrier to the development of the profession and enhanced services being provided to the public."